WO2007029998A2 - Reparation de defectuosites osseuses - Google Patents
Reparation de defectuosites osseuses Download PDFInfo
- Publication number
- WO2007029998A2 WO2007029998A2 PCT/MY2006/000009 MY2006000009W WO2007029998A2 WO 2007029998 A2 WO2007029998 A2 WO 2007029998A2 MY 2006000009 W MY2006000009 W MY 2006000009W WO 2007029998 A2 WO2007029998 A2 WO 2007029998A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bone
- instrumentation
- fracture
- delivery
- fracture site
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 132
- 230000007547 defect Effects 0.000 title claims abstract description 60
- 230000008439 repair process Effects 0.000 title abstract description 6
- 239000012634 fragment Substances 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 15
- 238000001356 surgical procedure Methods 0.000 claims abstract description 11
- 239000007943 implant Substances 0.000 claims abstract description 10
- 206010017076 Fracture Diseases 0.000 claims description 54
- 238000013519 translation Methods 0.000 claims description 27
- 230000033001 locomotion Effects 0.000 claims description 10
- 238000003780 insertion Methods 0.000 claims description 9
- 230000037431 insertion Effects 0.000 claims description 9
- 230000006835 compression Effects 0.000 claims description 6
- 238000007906 compression Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 210000001624 hip Anatomy 0.000 claims description 4
- 210000003423 ankle Anatomy 0.000 claims description 3
- 210000001513 elbow Anatomy 0.000 claims description 3
- 210000003127 knee Anatomy 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 210000002832 shoulder Anatomy 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 210000000707 wrist Anatomy 0.000 claims description 3
- 230000007812 deficiency Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 241000321728 Tritogonia verrucosa Species 0.000 claims 4
- 230000002950 deficient Effects 0.000 claims 3
- 238000005056 compaction Methods 0.000 claims 2
- 238000012856 packing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 30
- 210000001519 tissue Anatomy 0.000 abstract description 14
- 238000012937 correction Methods 0.000 abstract description 12
- 230000009467 reduction Effects 0.000 abstract description 7
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000002787 reinforcement Effects 0.000 abstract description 3
- 238000012800 visualization Methods 0.000 abstract 1
- 239000000316 bone substitute Substances 0.000 description 42
- 208000010392 Bone Fractures Diseases 0.000 description 40
- 239000002639 bone cement Substances 0.000 description 19
- 206010010214 Compression fracture Diseases 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 9
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 9
- 229940112869 bone morphogenetic protein Drugs 0.000 description 9
- 239000004568 cement Substances 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 210000000963 osteoblast Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000003102 growth factor Substances 0.000 description 6
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- 210000001564 haversian system Anatomy 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 4
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 3
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005553 drilling Methods 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 210000004409 osteocyte Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 206010001526 Air embolism Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 0 CCC1=*(C2)[C@@]2(C)C(C)*1 Chemical compound CCC1=*(C2)[C@@]2(C)C(C)*1 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000024779 Comminuted Fractures Diseases 0.000 description 2
- 206010020100 Hip fracture Diseases 0.000 description 2
- 206010023509 Kyphosis Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 206010041549 Spinal cord compression Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 230000003592 biomimetic effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 206010041569 spinal fracture Diseases 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 101150061927 BMP2 gene Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 206010070918 Bone deformity Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010018720 Greenstick fracture Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000008457 Neurologic Manifestations Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000010191 Osteitis Deformans Diseases 0.000 description 1
- 206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 208000027868 Paget disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 238000007469 bone scintigraphy Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000022159 cartilage development Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000009067 heart development Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 208000027202 mammary Paget disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000003988 neural development Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000009251 neurologic dysfunction Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000000010 osteolytic effect Effects 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000001144 postural effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
- A61B17/8822—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by means facilitating expulsion of fluid from the introducer, e.g. a screw pump plunger, hydraulic force transmissions, application of vibrations or a vacuum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
- A61B17/8811—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the introducer tip, i.e. the part inserted into or onto the bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/885—Tools for expanding or compacting bones or discs or cavities therein
- A61B17/8852—Tools for expanding or compacting bones or discs or cavities therein capable of being assembled or enlarged, or changing shape, inside the bone or disc
- A61B17/8858—Tools for expanding or compacting bones or discs or cavities therein capable of being assembled or enlarged, or changing shape, inside the bone or disc laterally or radially expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
Definitions
- the present invention relates generally to the field of surgical instrumentation and methods for the tissue-engineering treatment of skeletal fractures or deformities. More particularly, it relates to fractures or deformities in areas of the human body which are difficult to access, such as the spine, shoulder, elbow, wrist, hip, knee and ankle.
- the invention specifically describes instrumentation and methods for the precise reduction, relocation or removal of fractured bone parts, the structural reinforcement of fractured bone, and the delivery of tissue engineering materials to aid in repair and regeneration.
- Cortical bone makes up 80% of the skeleton, and is found in the outer shell of bone. It is composed of tightly-packed Haversian systems (osteons), comprising small, concentric, lamellar cylinders surrounding a central, vascular channel, connected by Haversian canals. Haversian canals contain capillaries, arterioles, venules and nerves. Between these osteons are interstitial lamellae.
- Haversian systems osteoons
- Haversian canals contain capillaries, arterioles, venules and nerves. Between these osteons are interstitial lamellae.
- Cancellous bone is less dense and more elastic than cortical bone, and also has a higher turnover rate than cortical bone. It is organised in trabecular struts, with lamellae running parallel to the trabeculae. It is located in the epiphyseal and metaphyseal regions of long bones and throughout the interior of short bones.
- Immature or pathologic bone is woven and more random, with more osteocytes than lamellar bone. It is the product of rapid bone formation, resulting in an irregular, disorganised pattern of collagen orientation and osteocyte distribution. It occurs in response to bony injury and dramatic changes in mechanical stimulation, and provides a temporary mechanical adjunct to allow bone to maintain or return quickly to its role as a structural support.
- AIl bone tissue is composed of a matrix that primarily consists of collagen protein, but is strengthened by deposits of calcium, hydroxyl and phosphate salts, referred to as hydroxyapatite. Inside and surrounding this matrix lie the cells of bone tissue, which include osteoblasts, osteocytes, osteoclasts and bone-lining cells. All four of these cell types are required for building and maintaining a healthy bone matrix, as well as remodelling of the bone under certain conditions.
- Bone fractures are among the most common orthopaedic complaints, and can be caused by a number of factors including trauma, osteoporosis, disease (e.g. Paget's disease) and bone tumours.
- Bone fracture classifications as referred to in this specification include comminuted fractures, as well as greenstick fractures, compound fractures, spiral fractures, transverse fractures and compression fractures.
- Compression fractures occur when two bones are forced against each other.
- Vertebral compression fractures occur most frequently in patients suffering osteoporosis or cancer (up to 70% of patients with cancer and multiple myeloma have osteolytic involvement of the spine (Lieberman & Reinhardt, Clin Orthop. 2003 Oct;(415 Suppl):S 176-86)) and are an extremely painful form of bone defect that can result in profound postural changes (e.g. pronounced stooping).
- VCFs include diseases such as osteogenesis imperfecta and ankylosing spondylitis, as well as trauma such as hyperextension-hyperflexion injury and stress fractures among athletes.
- One technique that attempts to provide correction of these deformities of a vertebral body in a VCF is performed using pins inserted into the damaged vertebra and the adjacent vertebrae, or the placement of a piece of the patient's own bone (e.g. from the pelvis) in the space occupied by the intervertebral disc above and/or below the damaged vertebra. These procedures act to "fuse" the damaged vertebral disc.
- the fused vertebrae act as "one" solid bone, allowing virtually no movement between the fused vertebrae and reducing spinal flexibility to some extent. This reduces the movement of the damaged vertebra and causes fracture healing, thus reducing the pain caused by movement.
- Percutaneous vertebroplasty is a procedure used to treat painful vertebral body compression fractures, which involves injecting polymethyhnethacrylate, a liquid cement, into the fractured vertebral body to restore the volume and strength of a vertebra (Le. structural stabilisation). The cement thus stabilises the fracture.
- Vertebroplasty affects the nerves responsible for the pain felt after the fracture, hence the procedure is performed for pain control, to correct deformity and to prevent further deformity.
- Balloon kyphoplasty offers an advantage over older surgical approaches through the insertion of a deflated balloon (bone tamp) into the bone defect, inflation of the balloon and thus the vertebra, and the use of polymethyhnethacrylate to fill the space occupied by the balloon. The procedure thus restores height to the compressed vertebra, as well as vertebral stability. Accordingly, any kyphosis (curvature of the spine, and in particular, posterior convexity of the vertebrae) that is present can be corrected using the kyphoplasty technique. Devices used in this method, and the method itself, are described in US patent numbers 5972015 and 6066154. However, balloon kyphoplasty relies on (uncontrolled) global expansion to correct the deformity.
- kyphoplasty and vertebroplasty are associated with several drawbacks, including an increased risk of vertebral fracture after a kyphoplasty procedure, consequential to the pressure placed on the spinal column from the cement used in the procedure (Frilaub et al, Spine. 2004 Oct 15;29(20):2270-6; Spivak et al., supra), and an increased risk of rib fracture for kyphoplasty (Spivak et al., supra). Both kyphoplasty and vertebroplasty involve the risk of patient reactions to the use of the polymethyhnethacrylate bone cement, (e.g.
- both vertebroplasty and kyphoplasty are associated with a risk of cement leakage, with vertebroplasty being linked with a higher risk of such leakage than kyphoplasty, as well as neurologic dysfunction through nerve damage, and a risk of pulmonary embolism from cement leakage into the vascular system (Spivak et al, Jour Am Acad Orth Surg 2005, 13(1):6-17).
- a kit suitable for use in vertebroplasty is disclosed in US 2004/0092946.
- This kit may comprise a cannula, a stylet, a micro-reamer, a catheter and a syringe. All of these instruments may be used to enable the delivery of restorative or injectable compositions into an intraosseous space or surgical defect.
- An expandable micro- reamer is described in this application, for creating or enlarging a space to make it suitable for receipt of a composition.
- the reamer comprises expandable leaves in communication with an outer shaft and surrounding an inner shaft. The leaves are expanded by rotation of a knob to create uniform radial expansion. The leaves may be configured for cutting and/or compressing bone to create the desired cavity.
- the expandable leaves of this device are akin to the balloons traditionally used in kyphoplasty. As such, the uniform expansion of the reamer can only really help to separate bone and not enable translation and re-alignment.
- kits are disclosed in US 2004/0167625.
- This particular kit comprises an expandable spacer and a quantity of a precursor to a biocompatible elastic material.
- This particular kit provides an inter-vertebral spacer or implant that can be inserted using a narrow diameter needle. It does not teach translation and/or re-alignment of a bone fracture to its preferred anatomical position.
- the present invention relates to a surgical instrument capable of the controlled synchronous correction of both anatomical and internal structural deficiencies of fractured or otherwise deformed bone.
- the said anatomical corrections comprise but are not limited to correction of translational, rotational and angular deformities as well as the reduction of fractures through the multi-axial, multi-planar divarication of compressed or compacted bone fragments; and the said internal structural corrections comprise but are not limited to the measured delivery and accurate placement of shaped scaffolds, discrete structural micro-implants, biomimetic constructs, or injectable fluids for the reinforcement and reconstruction of living bone tissue (hereafter, the said shaped scaffolds, discrete structural micro-implants, biomimetic constructs and injectable fluids are referred to as bone replacement materials).
- the instrumentation is equipped with mechanical devices to translate, rotate or realign collapsed or compacted bone and bring it into a desirable anatomical position.
- the instrumentation comprises a precision-controlled tip assembly at the distal portion of an elongate catheter body.
- the tip assembly has an enlarging end portion, wherein the end portion comprises a plurality of spring-like flanges, capable of divaricating and translating compressed or compacted bone fragments.
- the spring-like flanges (hereafter referred to as elevation arms) can each be controlled / actuated individually, may be rotated in any plane around the axis of the catheter, and have asymmetric shapes, thus allowing the operating surgeon to optimally address the area of defect that requires the most attention / correction.
- the spring-like flanges or elevation arms elevate and translate in an elliptical manner, relative to a long axis of the catheter body.
- the elevation arms come in a multitude of shapes and arc radii, allowing the operating surgeon to select the precise intraosseous relocation of bone fragments required by the patient.
- the elevation arms are controlled precisely and individually by a trigger on the body / handle of the instrument.
- the elevation arms may be rotated around the axis of the catheter by means of a geared drive.
- the elevation arms may be moved in and out of the bone or up and down along the axis of the bone to cause the necessary correction of rotational and angular defects.
- these motions may be caused by cam- wheels mounted close to the handle of the instrument, either transverse or parallel to the axis of the catheter.
- the instrument comprises a suction drilling assembly insertable through the same or parallel catheter or cannula for the removal of tissue debris.
- the suction drilling assembly is operable simultaneously with the tip assembly which divaricates and translates compressed or compacted bone.
- the elevation arms further include a scaffold fitted over or inside the arms, said scaffold for compressing fragments of the bone defect towards the outer surface of the scaffold.
- the scaffold is pre-shaped to the normal anatomical shape of the bone.
- the scaffold is in a folded state upon insertion into the fracture, further wherein a trigger actuates the elevation arms causing expansion of the scaffold to an expanded or final state.
- a trigger actuates the elevation arms causing expansion of the scaffold to an expanded or final state.
- the instrumentation may disengage from the scaffold to allow it to remain within the intraosseous space.
- the scaffold may be removed from the intraosseous space by the end of the surgical procedure.
- the scaffold may be constructed of biocompatible metals, shape memory metals or alloys. Still more preferably, the scaffold may be made of biodegradable, resorbable polymers of any description.
- an access passage into the bone defect is formed by a trocar.
- a cannulated system based on Seldinger technique is used to gain entry into the body of the bone.
- the guide wire is extruded from the expandable tip of the catheter body through the access passage.
- the surgical instrument is removed while the trocar is kept in place and a second gun like device is inserted, the second device having similar mechanical properties to the first except that it delivers the bone replacement material in a controlled and accountable (measurable) way.
- the second device may obtain materials stored in one or more chambers found on the body of said second device, and deliver these materials to the fracture site using various mechanical delivery methods.
- such mechanical delivery methods are a screw conveyor, or ratcheted system, or discrete particles threaded on a guide wire etc.
- the said second device incorporates a pressure gauge to ascertain the pressure generated by filling the fracture gap with the bone replacement material.
- the surgical instrument described above may itself provide for delivery of bone replacement material without the need for a second device.
- the surgical instrument has all the features, instrumentation and assemblies of the said second device.
- the instrument may allow for the addition of electronic features enabling it to be used for Computer Aided Surgery/ Navigation. Also, the instrument may allow for the deployment of an endoscope through the same access passage, allowing the operating surgeon to visualise the fracture region.
- the invention relates to a surgical instrument for introducing bone replacement material into a bone defect through an access passage, comprising a precision- controlled tip assembly, said precision tip comprising an elongate catheter body with an enlarging end portion, wherein the end portion comprises a plurality of spring-like expandable flanges, which can be individually controlled, said tip for providing elevation and/or translation of a bone defect, said flanges further providing rotation and angulation, and said catheter further providing for delivery of a bone replacement material.
- said end portion is removed prior to delivery of said bone replacement material.
- Said bone material may be delivered to the surgical instrument through a second precision ratchet device that allows for control of amount of material, pressure and shape of the final delivered material.
- the elevation arms further include a scaffold fitted over or inside the arms, said scaffold for compressing fragments of the bone defect towards the outer surface of the scaffold.
- the scaffold is removed along with the expandable arms prior to insertion of the bone replacement material.
- the scaffold is retained after insertion of the bone replacement material.
- the same trigger actuates expansion of the elevation arms and the delivery of the bone replacement material.
- different triggers actuate expansion of the elevation and translation arms and the delivery of the bone replacement material.
- the bone replacement material is bone cement.
- the bone replacement material is a bone paste comprising hydroxyapatite crystals and at least one growth factor.
- the hydroxyapatite crystals are hexagonally shaped, thus allowing them to gain rapid initial stability in the bone / fracture defect due to their forming a honeycomb like self-reinforcing structure.
- the material to fill the defect created by the fracture can be polymethylmethacrylate cement or some types of gel which harden after a certain time period or any type of biologic or non-biologic bone scaffold available.
- the bone paste further comprises osteoblast precursor cells.
- the osteoblast precursor cells are adult stem cells.
- the osteoblast precursor cells are embryonic stem cells.
- the osteoblast precursor cells are haematopoietic stem cells.
- the haematopoietic stem cells are derived from monocyte precursor cells.
- the at least one growth factor is selected from the group consisting of the bone morphogenetic protein (BMP) family members.
- BMP bone morphogenetic protein
- the BMP is BMP-2.
- the bone replacement material can be 'norian' or 'calcibon' crystals or 'geneX' (these are all trade names). These are made of calcium sulphate or calcium phosphate or a mixture of the two.
- the present invention is particularly suitable for use when the bone defect is a vertebral compression fracture (VCF).
- the bone defect may be a non- vertebral fracture including tibial plateau fractures and other compression type fractures.
- the present invention may be useful for correcting all types of compression fractures.
- a surgical instrument may incorporate endoscopic features and be fitted with electronics for Computer Aided Surgery.
- a Navigation Device may be a surgical instrument according to the present invention.
- Figure 1 is a schematic representation showing a vertebral compression fracture from a lateral perspective.
- Figure 2 is a schematic representation showing a guide wire being extruded from an expandable tip of a surgical instrument according to the present invention.
- Figure 3 is a dorsolateral perspective of the device shown in Figure 2 showing advancement of the expandable tip into a collapsed vertebral body.
- Figure 4 is an enlarged schematic representation of the device shown in Figure 2, showing placement of the expandable tip in the collapsed vertebral body.
- Figure 5 is an enlarged schematic representation of the device shown in Figure 2, showing actuation of the expandable tip into an expanded state in the collapsed vertebral body.
- Figure 6 is a schematic representation of the device shown in Figure 2, showing location of bone replacement material in the expandable device.
- Figure 7 is an enlarged schematic representation of the device shown in Figure 5, showing delivery of bone replacement material to the expandable tip.
- Figure 8 is a schematic representation of a surgical instrument according to the present invention being used for delivery of bone replacement material to a hip fracture.
- Figure 9A is a schematic representation of a device or gun for the delivery of bone replacement material or cement, according to the present invention.
- Figure 9B is an alternative device to that of Figure 9A.
- Figure 10 is a schematic representation of the assembly of a particular surgical instrument according to the present invention.
- Figure 11 is an enlarged view of a bush employed in the assembly of Figure 10. (The dimensions of such a bush may vary according to the type of fracture to be fixed.)
- Figure 12 is an example of an inner shaft employed in the assembly of Figure 10.
- Figure 13 A is a longitudinal cross-sectional view of the end of a particular outer shaft that may be employed in the assembly of Figure 10.
- Figure 13B is view from above of the end of the particular outer shaft shown in cross- section in Figure 13 A.
- Figure 14 is an example of a spring arm employed in the assembly of Figure 10.
- the spring arm may be made of tempered steel like a watch spring or shape memory metal alloy for example titanium, the dimensions of which may vary depending on the fracture to be fixed.
- Figure 15 is an example of an outer shaft employed in the assembly of Figure 10.
- Figure 16 is an example of a pusher tip which may be required when going through soft tissues or bony tissues.
- Figure 17 is another example of an assembly of a particular surgical instrument according to the present invention.
- the present invention is based on the development of a device for treating bone defects that provides not only elevation or separation of compressed bone defects, but also translation of the bone defect to its original load-bearing axis line.
- the present invention can be used to reduce and correct a bone defect and deliver a bone replacement material or tissue engineering construct to a bone defect in a patient. This may be performed by
- a device comprising elevation arms with controllable multi-directional motion, into the defect through the access passage, wherein the arms are in a generally collapsed geometry, said arms being provided through or on an elongate catheter body having a controllable tip assembly, wherein the tip assembly comprises a plurality of arms;
- patient refers to patients of human or other mammal and includes any individual it is desired to examine or treat using the device of the present invention.
- Suitable mammals that may benefit from use of the device include, but are not restricted to, primates, livestock animals (e.g. sheep, cows, horses, donkeys, pigs), laboratory test animals (e.g. rabbits, mice, rats, guinea pigs, hamsters), companion animals (e.g. cats, dogs) and captive wild animals (e.g. foxes, deer).
- compression when used in relation to a bone defect herein refers to a decrease in height of a bone, along the load-bearing axis line, which occurs when a bone is fractured or otherwise damaged.
- Bone fracture refers to a break in a bone that results in malalignment due to separation of fragments or collapse but could also be fracture without separation or collapse.
- translation or “translational deformity” of a bone defect as used herein refers to a parallel staggering of the longitudinal axis line or depth of a bone that occurs when the bone is fractured.
- bone defect and “bone fracture” are used interchangeably herein, and refer to an abnormal aperture, breakage or other inadequacy in a normal anatomical shape of a bone, which may result from a bone growth disorder, disease, trauma or other condition.
- elevation and separation refer to the process of dividing surfaces of a bone defect in order to create an aperture in the defect.
- the processes of elevation and/or separation are employed, and translation, where required, to return a misshapen bone (caused by the bone defect or fracture) to the normal, anatomical shape of the bone, through correction of rotation, angulation and translation of the fracture or defect.
- the access passage can be formed by any suitable means, such as via a trocar.
- the catheter body passes through the access passage created by the trocar by virtue of being passed along a guide wire that has firstly been inserted through the access passage into the bone defect.
- the guide wire is extruded from the tip of the elevation and translation arms into the bone aperture. Extrusion of the guide wire from the expandable structure may be actuated by any means suitable, such as by trigger action or by using a ratchet device which is controlled at the handle of the device.
- the device is suitable for use through open incisions, such as in minimal incision surgery (MIS) that reveal a bone having a defect, or it may be used endoscopically or in combination with a navigation system.
- MIS minimal incision surgery
- the elevation arms of the structure are actuated via a trigger on the catheter body or a ratchet device on the handle.
- the elevation arms of the expandable structure may expand in an elliptical or circular manner, relative to the longitudinal axis of the catheter body, to separate, elevate and/or translate the bone defect to its normal, anatomical shape. In this manner, bone fragments that are present in the bone defect are pushed towards the periphery of the defect prior to delivery of the bone replacement material.
- the elevation arms of the structure are covered by an expandable scaffold, which is preferably anatomically pre-shaped to the normal anatomical structure of the bone, in an unfractured or non-defected state.
- normal anatomical structure of the bone refers to the non- fractured and non-translated position of the bone, such that the shape of the bone is substantially returned to its non broken state (i.e. separated or non-compressed) and non-staggered state along its load-bearing axis (i.e. non-translated).
- Such a scaffold may be made from any suitable, expandable biocompatible material such as titanium mesh, stainless steel mesh, zirconium oxide mesh, ceramic tricalcium phosphate mesh, polymers, ceramics, tantalum, zirconium, polylactic acid, polyglycolic acid, bone substitutes, combinations of materials or the like.
- suitable, expandable biocompatible material such as titanium mesh, stainless steel mesh, zirconium oxide mesh, ceramic tricalcium phosphate mesh, polymers, ceramics, tantalum, zirconium, polylactic acid, polyglycolic acid, bone substitutes, combinations of materials or the like.
- the replacement bone tissue may comprise an artificial bone replacement material, such as a bone cement such as polymethyhnethacrylate (PMMA) or commercially available bone substitutes like 'norian' or 'calcibon' or 'geneX'.
- a bone cement such as polymethyhnethacrylate (PMMA) or commercially available bone substitutes like 'norian' or 'calcibon' or 'geneX'.
- a hard divarication, relocation and translation such as that achieved by the devices of the present invention thus provides both increased pressure/force in a closed space and directed and controllable pressure and/or force on fracture fragments (translation).
- the devices of the present invention are thus more controllable and precise than those employed in balloon kyphoplasty.
- An additional difference is that the same device or a second device of similar shape can be inserted, which allows delivery of the bone replacement material or tissue engineering constructs in a controlled and measurable fashion by way of any of a combination of mechanical devices which maintain pressure while measuring the amount of payload added and the amount remaining in the storage chamber.
- This preloaded delivery device is also airtight thus preventing the possibility of air being introduced into the system and thus preventing the theoretical possibility of air embolism.
- the expandable structure of the present invention also allows for use of a pre-shaped scaffold to expand (so allowing more accurate reduction of fracture fragments onto a pre-shaped structure that is shaped to the normal anatomical structure of the fractured bone).
- the bone replacement material is actuated by a trigger on the handle of the device.
- the bone replacement material may comprise a bone paste.
- bone paste refers to a bone replacement material that promotes growth of replacement bone tissue within a bone defect.
- the bone paste comprises hydroxyapatite bone crystals and growth factors.
- the hydroxyapatite crystals of the bone paste are polyhedral in shape.
- the bone paste comprises at least one osteoblast growth factor.
- the at least one growth factor is a bone morphogenetic protein (BMP).
- BMPs are a group of related proteins originally identified by their presence in bone-inductive extracts of demineralized bone. Molecular cloning has revealed at least six related members of this family, which have been designated BMP- 2 through BMP-7. These molecules are part of the TGF- ⁇ superfamily.
- the BMPs can be divided into subgroups with BMP-2 and BMP-4 being 92% identical, and BMP-5, BMP-6, and BMP-7 being an average of about 90% identical.
- Single BMP molecules, such as BMP-2 are capable of inducing the formation of new cartilage and bone (Li et al, J Spinal Disord Tech. 2004 Oct;17(5):423-8). Whether each of the BMPs possesses the same inductive activities in an animal is the subject of ongoing research. Studies of transgenic and knockout mice and from animals and humans with naturally occurring mutations in BMPs and related genes have shown that BMP signaling plays critical roles in heart, neural and cartilage development (Chen et al, Growth Factors.2004 Dec;22(4):233-41).
- the BMP is BMP-7. In an even more preferably form, the BMP is BMP-2.
- the bone paste further comprises osteoblast precursor cells, which may be adult stem cells, embryonic stem cells, haematopoietic stem cells or stem cells derived from monocyte precursor cells.
- an expandable scaffold is used that is expanded through the actions of the elevation arms of the device, and which is preferably shaped to the original anatomical shape of the bone defect.
- anatomical modelling studies are performed for shaping the scaffold to optimise the scaffold shape to fit the site where replacement bone is required in the patient.
- anatomical modelling studies can be employed, such as computed tomography or magnetic resonance imaging.
- the anatomical modelling studies may further include use of computer-aided design and computer controlled milling machines and / or selective laser melting machines.
- the scaffold can be nano, micro or macroparticle size.
- the scaffold When the scaffold is expanded, it acts to compact bone fragments within the bone defect to an exterior surface of the scaffold and thus the periphery of the bone defect.
- the scaffold may then optionally be removed, along with the elevation and translation arms of the device, prior to insertion of the bone replacement material.
- the scaffold may be retained in situ within the bone defect, where it can act to retain the bone replacement material.
- the scaffold may or may not comprise a bioabsorbable material.
- bioabsorbable materials are well known and include, but are not limited to, poly-L-lactic acid (PLLA), polyglycolic acid and polyglyconate.
- the trigger used to actuate and control the elevation arms of the expandable structure may be the same or separate from the trigger that actuates delivery of the bone replacement material.
- the configuration of the catheter and trigger/s may thus take the form of a "gun"-like instrument. In fact two different gun like devices may be used. The first to elevate and translate the compressed bone in a controlled manner and the second to deliver the bone substitute, cement or gel in a precise controlled and measurable fashion to a pre-set or measurable pressure for example 300 psi or 350 psi.
- Navigation for the placement of the elevation and translation arms may be performed, using but not restricted to equipment such as Brainlab / Zimmer systems, Stryker systems, DePuy systems or Medtronic systems. Navigation will guide accurate placement of gun and accurate use to reduce fractures with minimal tissue dissection and an imaging system is preferably employed to ensure correct placement of the bone replacement material, bone paste and/or expandable scaffold.
- imaging systems include, but are not limited to, radiolucent image intensifiers for biplanar fluoroscopy. Imaging systems also include computer assisted tomogram (CT) scanning systems or magnetic resonance image (MRI) systems. Also design will include option of instrumentation made of non-magnetic material for use under MRI (open or closed) navigation systems.
- the elevation arms are returned to their collapsed state prior to removal of the tip from the bone defect.
- the elevation arms of the tip structure may be returned to their collapsed state using any suitable mechanism.
- the tip comprises elevation arms actuated by a trigger or ratchet like handle, opposite movement of the trigger or ratchet can be employed to retract the arms prior to removal of the tip from the bone defect.
- the devices of the invention may be used to reconstruct a vertebral body that has been damaged and/or fractured by cancer (metastases), particularly where the patient is experiencing pain.
- the devices of the invention may also be employed for vertebral body damage that has occurred through trauma either due to osteoporotic compression fractures or accidents and falls causing acute compression fractures but not restricted to these indications where non-union or progressive kyphosis has developed.
- the main indication for operation would be pain.
- Other indications include correction of deformity and restoration of structure to be as close as possible to normal anatomical structure.
- the devices of the invention can be applied to most, if not all, fractures of the musculo-skeletal system, especially those with a crush or compression component.
- the advantages of certain embodiments of the invention thus include the benefits of MIS Surgery (or percutaneous techniques), which are well known.
- MIS Surgery or percutaneous techniques
- the divarication, relocation, translation, rotation and angulation structures of the invention are capable of being used in MIS to provide divarication or relocation of bone fragments, and translation, rotation and angulation of the fracture.
- the devices of the invention seek to provide such repair of a bone defect with greater precision and control than any devices previously available because the elevation arms can be individually controlled in any direction.
- an in- vivo tissue engineering capacity is employed, that can utilise the patient's own tissue (e.g. bone marrow stem cells).
- the problems of bone loss, rejection and complications of mechanical implant wear are avoided.
- This embodiment of the invention thus avoids the use of fillers such as acrylic cement with their problems of high temperature setting, leakage (with possible neural and vascular damage), embolization, adjacent fracture precipitation and infection.
- MIS minimally invasive surgical
- a patient having a vertebral compression fracture (Figure 1) undergoing surgery in the present example is firstly tested for the above-mentioned conditions.
- the standard pre-operative planning (with radiographs, CT, MRI and Bone scan imaging) for bony and spinal surgery is applied.
- An evaluation is routinely made of the existing cancer (and metastases) and also of the presence of osteoporosis (and risk factors).
- the patient is positioned prone on a radiolucent table.
- An Image Intensifier for biplanar (posterio-anterior and lateral) fluoroscopy is required.
- the patient is anaesthetised using general anaesthesia or regional / local anaesthesia.
- the operative technique employed used the transpedicular approach. However, some surgeons may elect to use the extrapedicular approach.
- Translation / elevation arms are elevated and used to elevate / translate the fracture ( Figure 5).
- the trigger actuates slow elevation of the arm tips until the fracture is elevated and translated ( Figure 5).
- the second trigger is then actuated to inject the bone paste
- a second injection gun is inserted into the first gun or into the trocar (working channel) - loaded and primed with payload (the bullet). This means that all air is extruded from the system during injection and thus there is no risk of air embolism.
- the delivery or injection gun has 2 properties - it allows controlled volumes of payload to be injected and at controlled pressure direction and velocity thus allowing complete control, feedback and precision to the surgeons' hands.
- the delivery / injection gun is preferably a spring loaded ratchet type gun like the one used to inject cement in total hip arthroplasty.
- the wound is closed using standard techniques.
- the patient is mobilised as soon as pain allows. Bracing is an option for some patients.
- the elevation and translation structures of the invention may also be utilised for delivery of bone replacement material to non-vertebral body fractures, such as but not limited to hip fractures or tibial plateau fractures ( Figure 8).
- FIG. 10-17 A particular embodiment of a device 10 according to the present invention is illustrated in Figures 10-17.
- This comprises an inner shaft 11 with a pusher 12 and a spacer 13 disposed at one end and expandable arms 14 disposed at the other end.
- An outer shaft 16, which is slightly shorter than the inner shaft 11, is disposed around the inner shaft 11 such that relative axial movement of the two shafts is permitted.
- One end of the outer shaft 16 includes apertures 20 to allow radial projection of the translation / elevation arms 14 from within.
- a cap 21 is provided adjacent the apertures 20 to retain the inner shaft 11 within the outer shaft 16.
- the outer shaft 16 is also fitted with a bush 17 and a handle 18, both disposed towards the end furthest away from the expandable arms 14 of the inner shaft 11.
- the bush 17 comprises a cylindrical receptacle 22 and a chamfered end 19.
- the spacer 13 attached to the inner shaft 11, may slide axially within the receptacle 22, which is attached to outer shaft 16 via bush 17. Consequently, a user (i.e. surgeon) may grip the handle 18 with his/her fingers and apply pressure on the pusher 12 with the palm or heel of his/her hand. This will force the spacer 13 into receptacle 22 until it abuts end stop 15. In turn, the opposite end of the inner shaft 11, away from the spacer 13, will be forced towards the far end of the outer shaft 16. This will cause the free ends of the expandable arms 14 to abut cap 21. Further pushing of inner shaft 11 towards cap 21 will force the arms 14 to expand outwards of the shaft axis. Conversely, easing pressure on the pusher 12 will allow the arms 14 to relax and return to an unexpended state.
- the end of the device 10, furthest from the pusher 12 may be inserted into a patient through an access passage formed using traditional surgical techniques.
- the device 10 will be inserted with the arms 14 in a relaxed or unexpended state.
- the user may expand the arms 14 by forcing the pusher 12 towards the handle 18.
- translation may be also be achieved by maintaining the relative positioning of the pusher 12 and handle 18, and moving the entire device 10 relative to the patient. Rotation and/or angulation may also be achieved in a similar manner.
- the inner shaft 11 and expandable arms 14 may be withdrawn, with the outer shaft 16 remaining in situ. Bone replacement material or cement may then be feed through the outer shaft 16 by use of a second gun 30, 40, such that the desired pressure and quantity can be delivered. After the required material has been delivered, both the gun 30, 40 and outer shaft 16 can be removed from the patient.
- the entire device 10, including the inner 11 and outer 16 shafts may be removed prior to insertion of the bone replacement material or cement.
- a separate device 30, 40 may be inserted for delivery of the bone replacement material or cement.
- gun 30 may be used to deliver the desired quantity of bone replacement material at a desired pressure setting.
- gun 40 illustrated in Figure 9B, may be employed whereby each complete rotation of pusher 41 within threaded barrel 42, delivers a fixed volume, say 0.5ml, of bone replacement material through shaft 43 when attached.
- a single expandable arm 14 may be employed for elevation and translation of certain bone defects.
- multiple arms 14 may be employed at a plurality of radial positions to suit particular circumstances.
- the size and profile of the expandable arms 14 and the apertures 20 may also be varied as desired.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Cette invention concerne un instrument permettant de réduire complètement, de réparer et de régénérer par génie tissulaire des défectuosités ou des difformités osseuses dues à des fractures, en particulier à des fractures situées dans des zones relativement inaccessibles du corps humain ou du squelette. L'instrument est peu effractif, permet de créer un passage unique avec une multitude de canaux possibles pour une multitude d'applications potentielles, telles que notamment, mais pas uniquement: extraction de débris, correction précise et maîtrisée de défauts de translation, de rotation et d'angularité d'un os, repositionnement et détassement précis et maîtrisé de fragments osseux, renforcement structural à l'intérieur du site de la fracture par la mise en place de divers micro-implants et apport de divers matériaux et constructions issus du génie tissulaire et destinés à faciliter la régénération de tissu osseux vivant sur le site de la fracture. L'instrument est en mesure de stocker les divers matériaux d'apport et d'en contrôleur l'emplacement, la quantité, la forme, le volume, l'alignement, l'orientation et la pression interne au moment de leur dépose sur le site de la fracture. De plus, cet instrument peut être adapté en vue de son utilisation avec diverses techniques de visualisation, de chirurgie assistée par ordinateur et de navigation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517933.8A GB0517933D0 (en) | 2005-09-05 | 2005-09-05 | Repair of bone defects |
GB0517933.8 | 2005-09-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007029998A2 true WO2007029998A2 (fr) | 2007-03-15 |
WO2007029998A3 WO2007029998A3 (fr) | 2007-05-31 |
Family
ID=35220788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MY2006/000009 WO2007029998A2 (fr) | 2005-09-05 | 2006-09-05 | Reparation de defectuosites osseuses |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0517933D0 (fr) |
WO (1) | WO2007029998A2 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8905996B2 (en) | 2010-11-01 | 2014-12-09 | Biomet Manufacturing, Llc | Cannulated syringe |
CN104815387A (zh) * | 2015-04-19 | 2015-08-05 | 苏州爱得科技发展有限公司 | 一种椎体扩张成形系统 |
CN104815388A (zh) * | 2015-04-19 | 2015-08-05 | 苏州爱得科技发展有限公司 | 一种椎体扩张成形系统 |
CN111839707A (zh) * | 2020-06-30 | 2020-10-30 | 陈丹华 | 一种椎体成形系统骨水泥推进器 |
WO2024129863A3 (fr) * | 2022-12-13 | 2024-07-25 | ThoraGenix Innovations, Inc. | Systèmes, procédés et dispositifs d'incitation de croissance osseuse au niveau d'un site de fracture osseuse |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059193A (en) * | 1989-11-20 | 1991-10-22 | Spine-Tech, Inc. | Expandable spinal implant and surgical method |
WO2001076492A1 (fr) * | 2000-04-07 | 2001-10-18 | Kyphon Inc. | Dispositifs d'insertion et procede d'utilisation |
WO2002019930A2 (fr) * | 2000-09-01 | 2002-03-14 | Synthes Ag Chur | Instrument de creusement de cavites dans un os et techniques a cet effet |
WO2004019756A2 (fr) * | 2002-08-29 | 2004-03-11 | Loubert Suddaby | Dispositif mecanique de tassement osseux pour la reparation de fractures osseuses osteoporotiques |
US20040092946A1 (en) * | 2001-02-20 | 2004-05-13 | Bagga Charanpreet S. | System and kit for delivery of restorative materials |
US20040267269A1 (en) * | 2001-06-01 | 2004-12-30 | Middleton Lance M. | Tissue cavitation device and method |
WO2006053210A1 (fr) * | 2004-11-12 | 2006-05-18 | Medtronic, Inc. | Dispositif de réhaussement implantable pour corps vertébral |
-
2005
- 2005-09-05 GB GBGB0517933.8A patent/GB0517933D0/en not_active Ceased
-
2006
- 2006-09-05 WO PCT/MY2006/000009 patent/WO2007029998A2/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059193A (en) * | 1989-11-20 | 1991-10-22 | Spine-Tech, Inc. | Expandable spinal implant and surgical method |
WO2001076492A1 (fr) * | 2000-04-07 | 2001-10-18 | Kyphon Inc. | Dispositifs d'insertion et procede d'utilisation |
WO2002019930A2 (fr) * | 2000-09-01 | 2002-03-14 | Synthes Ag Chur | Instrument de creusement de cavites dans un os et techniques a cet effet |
US20040092946A1 (en) * | 2001-02-20 | 2004-05-13 | Bagga Charanpreet S. | System and kit for delivery of restorative materials |
US20040267269A1 (en) * | 2001-06-01 | 2004-12-30 | Middleton Lance M. | Tissue cavitation device and method |
WO2004019756A2 (fr) * | 2002-08-29 | 2004-03-11 | Loubert Suddaby | Dispositif mecanique de tassement osseux pour la reparation de fractures osseuses osteoporotiques |
WO2006053210A1 (fr) * | 2004-11-12 | 2006-05-18 | Medtronic, Inc. | Dispositif de réhaussement implantable pour corps vertébral |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8905996B2 (en) | 2010-11-01 | 2014-12-09 | Biomet Manufacturing, Llc | Cannulated syringe |
US10413326B2 (en) | 2010-11-01 | 2019-09-17 | Biomet Manufacturing, Llc | Cannulated syringe |
CN104815387A (zh) * | 2015-04-19 | 2015-08-05 | 苏州爱得科技发展有限公司 | 一种椎体扩张成形系统 |
CN104815388A (zh) * | 2015-04-19 | 2015-08-05 | 苏州爱得科技发展有限公司 | 一种椎体扩张成形系统 |
CN111839707A (zh) * | 2020-06-30 | 2020-10-30 | 陈丹华 | 一种椎体成形系统骨水泥推进器 |
CN111839707B (zh) * | 2020-06-30 | 2021-07-20 | 陈丹华 | 一种椎体成形系统骨水泥推进器 |
WO2024129863A3 (fr) * | 2022-12-13 | 2024-07-25 | ThoraGenix Innovations, Inc. | Systèmes, procédés et dispositifs d'incitation de croissance osseuse au niveau d'un site de fracture osseuse |
Also Published As
Publication number | Publication date |
---|---|
WO2007029998A3 (fr) | 2007-05-31 |
GB0517933D0 (en) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12156686B2 (en) | Device for performing a surgical procedure and method | |
US9414929B2 (en) | Biologic vertebral reconstruction | |
JP5159320B2 (ja) | 三次元の移植可能な骨支持体 | |
RU2578032C2 (ru) | Способы лечения дегенеративных состояний костей | |
JP4990293B2 (ja) | フレキシブル細長チェーンインプラントおよび該インプラントを用いて体組織を支持する方法 | |
US8740954B2 (en) | Device and method for orthopedic fracture fixation | |
US9439702B2 (en) | Bone fracture reduction system and methods of using the same | |
US20120029578A1 (en) | Bio-Resorbable Capsule Containing Fenestrated Screw System For Osteoporotic Subject | |
WO2009094478A1 (fr) | Dispositif orthopédique extensible et procédé | |
US9161818B2 (en) | Device for performing a surgical procedure and method | |
US10258398B2 (en) | Device for performing a surgical procedure and method | |
US20140336710A1 (en) | Device and method for orthopedic fracture fixation | |
WO2007029998A2 (fr) | Reparation de defectuosites osseuses | |
US20110190776A1 (en) | Interosteal and intramedullary implants and method of implanting same | |
US9204915B2 (en) | Device for performing a surgical procedure and method | |
US9427272B2 (en) | Device for performing a surgical procedure and method | |
US9433455B2 (en) | Fracture fragment mobility testing for vertebral body procedures | |
US20160354130A1 (en) | Bone tamp and method of use | |
US20140277211A1 (en) | Device for performing a surgical procedure and method | |
RU2729027C2 (ru) | Устройство для восстановления высоты тела позвонка | |
Bakker et al. | New Developments and Perspectives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06799448 Country of ref document: EP Kind code of ref document: A2 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTIFICATION OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A SENT ON 10.09.08) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06799448 Country of ref document: EP Kind code of ref document: A2 |